Invite only: Precision prevention: biological mechanisms of response variation
Public Health, Clinical Pharmacology and Epidemiology invite-only biomedical research grant from Medical Research Council
Apply by Thursday, Nov 5
About
This invited full-application stage funds mechanistic human research into why biomedical prevention interventions work differently across people. Projects must test an experimental intervention or challenge in pre-disease or early-disease states, focus on a mechanistic hypothesis and use validated biological readouts to improve the targeting and effectiveness of precision-prevention strategies. Applicants must already have submitted the mandatory expression of interest and been invited to apply. Projects may request up to £5 million in full economic cost over five years; MRC normally funds 80%. Invited applications close on 5 November 2026 at 16:00 UK time.
Eligibility
Career stage: Not stated
Institution applies
Host location: United Kingdom
Reviewed Sep 24, 2026. Check the funder’s full conditions before applying.
Only teams invited after the mandatory expression-of-interest stage may submit. The project lead must be employed by an eligible research organisation, direct the project and remain actively engaged. International researchers may participate as project co-leads under UKRI's international eligibility policy; businesses and third-sector organisations cannot lead but may participate as project partners.
Topics
Related funding
- Closes Oct 21Innovate UK
Engineering Biology Collaborative R&D: Round 3
Closes Nov 3Innovate UKEngineering Biology Investor Partnerships round 1
Closes Dec 2Innovate UK
Open funding in Public Health
All fundingExpression of interest: Chemical, biological, radiological and nuclear (CBRN) medical countermeasures R&D
Closes Oct 20Medical Research Council (UKRI)
Source: ukri.org